- Home
- RGNX vs CLMB Comparison
RGNX vs CLMB Comparison
Compare RGNX & CLMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- CLMB
- Stock Information
- Founded
- RGNX 2008
- CLMB 1982
- Country
- RGNX United States
- CLMB United States
- Employees
- RGNX N/A
- CLMB N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- CLMB Retail: Computer Software & Peripheral Equipment
- Sector
- RGNX Health Care
- CLMB Technology
- Exchange
- RGNX Nasdaq
- CLMB Nasdaq
- Market Cap
- RGNX 451.1M
- CLMB 502.9M
- IPO Year
- RGNX 2015
- CLMB N/A
- Fundamental
- Price
- RGNX $9.26
- CLMB $132.84
- Analyst Decision
- RGNX Strong Buy
- CLMB Buy
- Analyst Count
- RGNX 8
- CLMB 1
- Target Price
- RGNX $28.50
- CLMB $136.00
- AVG Volume (30 Days)
- RGNX 528.4K
- CLMB 38.4K
- Earning Date
- RGNX 11-05-2025
- CLMB 10-29-2025
- Dividend Yield
- RGNX N/A
- CLMB 0.51%
- EPS Growth
- RGNX N/A
- CLMB 59.50
- EPS
- RGNX N/A
- CLMB 4.81
- Revenue
- RGNX $155,782,000.00
- CLMB $578,437,000.00
- Revenue This Year
- RGNX $203.27
- CLMB $28.14
- Revenue Next Year
- RGNX $0.58
- CLMB $5.89
- P/E Ratio
- RGNX N/A
- CLMB $27.57
- Revenue Growth
- RGNX 74.95
- CLMB 56.44
- 52 Week Low
- RGNX $5.04
- CLMB $88.90
- 52 Week High
- RGNX $13.48
- CLMB $145.00
- Technical
- Relative Strength Index (RSI)
- RGNX 52.58
- CLMB 66.31
- Support Level
- RGNX $8.82
- CLMB $124.54
- Resistance Level
- RGNX $10.08
- CLMB $133.54
- Average True Range (ATR)
- RGNX 0.55
- CLMB 3.23
- MACD
- RGNX -0.03
- CLMB 0.21
- Stochastic Oscillator
- RGNX 42.66
- CLMB 93.93
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About CLMB Climb Global Solutions Inc.
Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.